Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP) Effect of 16-week Dupilumab Treatment on Sinonasal Respiratory Symptoms and Sense of Smell in Ethnically Diverse Patients With Chronic Rhinosinusitis and Nasal Polyposis (CRSwNP)

NCT05246267 is registered in ClinicalTrials.gov with Montefiore Medical Center as lead sponsor.

NCT NCT05246267
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05246267 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP) Effect of 16-week Dupilumab Treatment on Sinonasal Respiratory Symptoms and Sense of Smell in Ethnically Diverse Patients With Chronic Rhinosinusitis and Nasal Polyposis (CRSwNP)
Lead sponsor
Montefiore Medical Center
Phase
Observational
Overall status
Active, not recruiting
Start date
February 15, 2022
Completion date
August 31, 2027
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic rhinosinusitis with nasal polyps